Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank79
3Y CAGR+38.7%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+38.7%/yr
vs -18.2%/yr prior
Acceleration
+56.8pp
Accelerating
Percentile
P79
Within normal range
vs 3Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.74M | -25.4% |
| 2024 | $2.34M | +1.1% |
| 2023 | $2.31M | +253.5% |
| 2022 | $654000.00 | +447.9% |
| 2021 | $-188000.00 | +37.7% |
| 2020 | $-302000.00 | -116.1% |
| 2019 | $1.87M | +28.5% |
| 2018 | $1.46M | +208.2% |
| 2017 | $473000.00 | +79.8% |
| 2016 | $263000.00 | - |